CEO.CA's Inside the Boardroom: This Breast Cancer Tech by Izotropic Targets 50% of Women Currently Underserved
Rhea-AI Summary
Izotropic Corporation (OTCQB: IZOZF) was featured in CEO.CA's "Inside the Boardroom" interview on October 21, 2025, where CEO Robert Thast discussed the company's breast cancer technology and strategy.
The interview positions the technology as targeting 50% of women currently underserved by existing screening or diagnostic options and invites investors to view the full conversation via CEO.CA and YouTube. The piece also promotes CEO.CA as an investor social network with broad engagement and weekly executive interviews.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, IZOZF gained 3.73%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Toronto, Ontario--(Newsfile Corp. - October 21, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.
Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience engagement and mobile functionality. Millions of people visit CEO.CA each year to connect with investors from around the world, share knowledge and view impactful stories about stocks, commodities, and emerging companies.
Meet the Executive Shaping the Bio Tech Landscape
'Inside the Boardroom' is more than just an interview series - it's a chance to gain firsthand knowledge from industry leaders, understanding their vision, challenges, and strategy.
We caught up with Robert Thast, CEO of Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3). Follow what investors are saying and join our community: https://ceo.ca/izo
Izotropic Corporation
(CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)
Cannot view this video? Visit:
https://www.youtube.com/watch?v=-0qCmBojFJk
Tune into 'Inside the Boardroom' each week and be part of the conversation that's shaping the business landscape. Visit CEO.CA or our YouTube page for hundreds more executive interviews from CEO.CA here.
Interested in showcasing your company on 'Inside the Boardroom'? Get in touch with our team at sales@ceo.ca for further details and opportunities.
About CEO.CA
The leading community for investors & traders in junior resource & venture stocks. CEO.CA is one of the most popular free financial websites and apps in Canada and for small-cap investors globally -- with industry leading audience engagement and mobile functionality. Since 2012, CEO.CA has brought millions of investors together from over 164 countries to discuss their portfolio holdings and find new investment opportunities. Download our App on iOS or Android marketplace or visit us today at CEO.CA to set up your free account.
CEO.CA is a wholly owned subsidiary of EarthLabs, Inc.
For further information please contact:
CEO.CA
Email: hello@ceo.ca
Website: CEO.CA
Neither the TSX Venture Exchange ("TSXV"), OTC Best Market "(OTCQX") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statement
The information regarding any issuer contained or referred to in any interviews conducted by CEO.CA has been furnished by such issuer directly, and neither CEO.CA nor any of its affiliates or principals assumes any responsibility for the accuracy or completeness of such information or for any failure by an issuer to ensure disclosure of events or facts which may affect the significance or accuracy of any such information.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This news release contains forward-looking information which involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the objectives, goals, future plans, statements regarding exploration results and exploration and/or development plans of companies featured on the CEO.CA platform. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, capital and operating costs varying significantly from estimates, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, fluctuations in commodity prices, delays in the development of projects, currency risk and the other risks involved in the applicable exploration and development industry, and those risks set out in the public documents of such companies filed on SEDAR or elsewhere from time to time. Undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. CEO.CA disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271210
FAQ
What did Izotropic (OTCQB: IZOZF) announce in the October 21, 2025 CEO.CA interview?
Where can investors watch the Izotropic (IZOZF) "Inside the Boardroom" interview from October 21, 2025?
Who is the CEO of Izotropic featured in the October 21, 2025 interview?
Does the CEO.CA interview provide financial or clinical trial data for Izotropic (IZOZF)?
How often does CEO.CA publish "Inside the Boardroom" interviews for companies like Izotropic (IZOZF)?
